O. S. AYDOS Et Al. , "Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways," Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease , Cambridge, Canada, 2016
AYDOS, O. S. Et Al. 2016. Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways. Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease , (Cambridge, Canada).
AYDOS, O. S., YÜKSELTEN, Y., BAL, M. G., Yükselen, I., AYDOS, K., & SUNGUROĞLU, A., (2016). Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways . Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease, Cambridge, Canada
AYDOS, OYA Et Al. "Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways," Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease, Cambridge, Canada, 2016
AYDOS, OYA S. Et Al. "Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways." Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease , Cambridge, Canada, 2016
AYDOS, O. S. Et Al. (2016) . "Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways." Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease , Cambridge, Canada.
@conferencepaper{conferencepaper, author={OYA SENA AYDOS Et Al. }, title={Analyzing the differences between Sertoli cells obtained from Nonobstructive Azoospermia and Obstructive Azoospermia patients for mitochondrial numbers and metabolic pathways}, congress name={Mitochondrial Medicine:Developing new treatments for Mitochondrial Disease}, city={Cambridge}, country={Canada}, year={2016}}